1058 related articles for article (PubMed ID: 30724351)
1. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
2. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
[TBL] [Abstract][Full Text] [Related]
3. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.
Kirby JS; Butt M; King T
Br J Dermatol; 2020 Apr; 182(4):940-948. PubMed ID: 31233623
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intrarater reliability of Hurley staging for hidradenitis suppurativa.
Ovadja ZN; Schuit MM; van der Horst CMAM; Lapid O
Br J Dermatol; 2019 Aug; 181(2):344-349. PubMed ID: 30585304
[TBL] [Abstract][Full Text] [Related]
5. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
6. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
Kimball AB; Ganguli A; Fleischer A
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
[TBL] [Abstract][Full Text] [Related]
7. Assessment of inter-rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography.
Lyons AB; Narla S; Kohli I; Zubair R; Nahhas AF; Braunberger TL; Joseph MK; Nicholson CL; Jacobsen G; Hamzavi IH
Clin Exp Dermatol; 2022 Feb; 47(2):319-324. PubMed ID: 34388853
[TBL] [Abstract][Full Text] [Related]
8. Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
Goldfarb N; Lowes MA; Butt M; King T; Alavi A; Kirby JS
Br J Dermatol; 2021 May; 184(5):905-912. PubMed ID: 32969027
[TBL] [Abstract][Full Text] [Related]
9. Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.
Ingram JR; Hadjieconomou S; Piguet V
Br J Dermatol; 2016 Aug; 175(2):263-72. PubMed ID: 26873867
[TBL] [Abstract][Full Text] [Related]
10. Inter-rater and intrarater agreement and reliability in clinical staging of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Matusiak Ł; Jemec GBE; Szepietowski JC; Álvarez-Chinchilla PJ; Asoskova A; Bonnekoh H; Brattoli G; Cetinarslan TS; Dawicka J; Dente V; Gallyamova Y; Giovanardi G; Glasenhardt K; Ionescu AM; Janushaj E; Lakhssassi MK; Lőrincz KK; Ludew D; Makmatov-Rys M; Malickova M; Mengesha SW; Mintoff D; Otlewska A; Papakou M; Pirvan AM; Provvidenziale L; Quadrana F; Savickaja N; Tamulyté G; Trifu A; Vīgante A; Włodarek K; Zouboulis VA
Br J Dermatol; 2019 Oct; 181(4):852-854. PubMed ID: 30968946
[No Abstract] [Full Text] [Related]
11. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
[TBL] [Abstract][Full Text] [Related]
12. Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa.
Frew JW; Hawkes JE; Sullivan-Whalen M; Gilleaudeau P; Krueger JG
Br J Dermatol; 2019 Sep; 181(3):566-571. PubMed ID: 30693478
[TBL] [Abstract][Full Text] [Related]
13. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
[TBL] [Abstract][Full Text] [Related]
14. New treatments and new assessment instruments for Hidradenitis suppurativa.
van Straalen KR; Ingram JR; Augustin M; Zouboulis CC
Exp Dermatol; 2022 Sep; 31 Suppl 1(Suppl 1):33-39. PubMed ID: 35582833
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Hidradenitis Suppurativa Self-Assessment Tool.
Senthilnathan A; Kolli SS; Cardwell LA; Richardson I; Feldman SR; Pichardo RO
J Cutan Med Surg; 2019; 23(4):388-390. PubMed ID: 30897946
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
[TBL] [Abstract][Full Text] [Related]
17. Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa.
Hasan SB; Gendra R; James J; Morris D; Orenstein LAV; Ingram JR
Br J Dermatol; 2022 Dec; 187(6):846-854. PubMed ID: 35962565
[TBL] [Abstract][Full Text] [Related]
18. Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence.
Hernández Montilla I; Medela A; Mac Carthy T; Aguilar A; Gómez Tejerina P; Vilas Sueiro A; González Pérez AM; Vergara de la Campa L; Luna Bastante L; García Castro R; Alfageme Roldán F
Skin Res Technol; 2023 Jun; 29(6):e13357. PubMed ID: 37357665
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
[TBL] [Abstract][Full Text] [Related]
20. Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials.
Garg A; Zema C; Kim K; Gao W; Chen N; Jemec GBE; Kirby J; Thorlacius L; Villumsen B; Ingram JR
Br J Dermatol; 2022 Aug; 187(2):203-210. PubMed ID: 35599448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
